Table 2 Prevalence rate and 95% confidence intervals (CI) of glucosamine prescribing for males and females for two age groups (70–74 years and ≥ 75 years) from 2002 to 2011
From: Prescribing patterns of glucosamine in an older population: a national cohort study
Year | Prevalence rate (per 1000 population) | |||
|---|---|---|---|---|
Males (95% CI) | Females (95% CI) | |||
70-74 years | ≥ 75 years | 70-74 years | ≥ 75 years | |
2002 | 11.1 (10.5-11.6) | 8.0 (7.6-8.4) | 21.0 (20.4-21.7) | 13.1 (12.6-13.6) |
2003 | 18.9 (18.3-19.5) | 14.2 (13.7-14.7) | 35.8 (35.0-36.6) | 23.3 (22.7-24.0) |
2004 | 25.1 (24.3-25.9) | 20.5 (19.9-21.2) | 50.0 (49.0-50.9) | 31.9 (31.1-32.6) |
2005 | 32.8 (32.0-33.5 | 25.4 (24.7-26.1) | 64.1 (63.1-65.2) | 39.5 (38.6-40.3) |
2006 | 38.1 (37.2-38.9) | 32.3 (31.5-33.1) | 73.6 (72.4-74.7) | 48.6 (47.6-49.5) |
2007 | 43.9 (43.0-44.8) | 37.8 (36.9-38.6) | 83.1 (81.9-84.3) | 56.2 (55.2-57.2) |
2008 | 49.1 (48.2-50.1) | 41.0 (40.1-41.9) | 94.8 (93.5-96.1) | 62.2 (61.1-63.2) |
2009 | 58.7 (56.8-60.7) | 46.3 (45.0-47.7) | 110.8 (108.3-113.3) | 68.6 (67.2-69.9) |
2010 | 58.0 (56.1-60.0) | 44.3 (42.9-45.6) | 109.7 (107.2-112.2) | 68.1 (66.8-69.5) |
2011 | 47.3 (45.7-49.0) | 43.3 (42.0-44.7) | 93.8 (91.6-96.0) | 67.2 (65.8-68.5) |